Combined treatment with denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC-3 cells. (Q37346528)
Jump to navigation
Jump to search
scientific article published on 18 May 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Combined treatment with denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC-3 cells. |
scientific article published on 18 May 2009 |
Statements
Combined treatment with denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC-3 cells (English)
C C Chen
1 reference
1 reference
1 reference
1 reference